Crystalline Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Crystalline Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-775,000	Closed	-$231K	–	154
2023 Q2	$231K	Buy	+775,000	New	+$234K	0.16%	76

Crystalline Management's GRNA Position: Q3 2023 in Review

Crystalline Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 775,000 shares — an estimated $231K sold.

Crystalline Management first reported a position in GRNA in Q2 2023 and held it in 1 quarter. The position peaked at $231K in Q2 2023. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Crystalline Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Crystalline Management sold 775,000 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $231K.
Crystalline Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2023 and held it in 1 quarter.
Crystalline Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $231K in Q2 2023.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Crystalline Management's 13F filing for Q3 2023, filed 13 Nov 2023.